Literature DB >> 20927493

Risk factors for readmission after hospital discharge in chronic obstructive pulmonary disease. The role of quality of life indicators.

Rui Carneiro1, Cristiana Sousa, Alexandre Pinto, Fernanda Almeida, Júlio R Oliveira, Nelson Rocha.   

Abstract

AIMS: To identify demographic, clinical, functional and inherent quality of life (QOL) and depression factors with impact on use of the Emergency Services (ES) or readmission after hospital discharge for acute exacerbation of chronic obstructive pulmonary disease (COPD) over a period of 66 weeks. QOL was evaluated by the St. George's Respiratory Questionnaire (SGRQ). The Beck Depression Inventory assessed depression. We prospectively evaluated 45 patients (84.4% male, median age 73 years, stage IV 51%). The median total SGRQ score was 50.6, with a greater impact on symptoms, especially in younger patients (r=-0.425; p=0.043), and activity limitation than emotional impact of the disease. More than half were depressed. Worse QOL meant depression (R=0.699; p=0.02). Low FEV1 correlated with depression (r=-0.46; p =0.05) but not with QOL. Long-acting anti-cholinergic bronchodilator and inhaled steroids improved QOL. Almost 85% of patients used ES (25.8% for exacerbated COPD). Rate of hospital readmission for all reasons and exacerbated COPD was 64.9% and 33.3%. The number of readmissions (all reasons) was correlated with age (R=0.48; p=0003), cor pulmonale (R=-0.46; p=0.03) and QOL (R=0.67; p=0.004). Depressed patients (R=0.51; p=004), with low FEV1 (R=-0413; p=0.04) and with cor pulmonale (R=-046, p=0.005) had more inhospital days for exacerbation of COPD. QOL and depression are variables to consider in the evaluation and treatment of patients with COPD as part of a set of clinical and functional data that can predict the risk of readmission after hospital discharge for exacerbated COPD.

Entities:  

Mesh:

Year:  2010        PMID: 20927493

Source DB:  PubMed          Journal:  Rev Port Pneumol        ISSN: 0873-2159


  7 in total

1.  Predictors of early readmission among patients 40 to 64 years of age hospitalized for chronic obstructive pulmonary disease.

Authors:  Roozbeh Sharif; Trisha M Parekh; Karen S Pierson; Yong-Fang Kuo; Gulshan Sharma
Journal:  Ann Am Thorac Soc       Date:  2014-06

2.  Functional Status and Hospital Readmissions Using the Medical Expenditure Panel Survey.

Authors:  Marina Soley-Bori; Rene Soria-Saucedo; Colleen M Ryan; Jeffrey C Schneider; Alex B Haynes; Paul Gerrard; Howard J Cabral; Keith D Lillemoe; Lewis E Kazis
Journal:  J Gen Intern Med       Date:  2015-02-18       Impact factor: 5.128

Review 3.  Examining the relationship between anxiety and depression and exacerbations of COPD which result in hospital admission: a systematic review.

Authors:  Alison Pooler; Roger Beech
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-03-29

4.  Effectiveness of Peri-Discharge Complex Interventions for Reducing 30-Day Readmissions among COPD Patients: Overview of Systematic Reviews and Network Meta-Analysis.

Authors:  Claire C W Zhong; Charlene H L Wong; William K W Cheung; Eng-Kiong Yeoh; Chi Tim Hung; Benjamin H K Yip; Eliza L Y Wong; Samuel Y S Wong; Vincent C H Chung
Journal:  Int J Integr Care       Date:  2022-02-03       Impact factor: 5.120

5.  Association of serum magnesium levels with frequency of acute exacerbations in chronic obstructive pulmonary disease: a prospective study.

Authors:  Aziz Gumus; Muge Haziroglu; Yilmaz Gunes
Journal:  Pulm Med       Date:  2014-11-18

6.  Understanding fear and anxiety in patients at the time of an exacerbation of chronic obstructive pulmonary disease: a qualitative study.

Authors:  David Halpin; Michael Hyland; Susan Blake; Clare Seamark; Margaret Pinnuck; David Ward; Ben Whalley; Colin Greaves; Adam Hawkins; David Seamark
Journal:  JRSM Open       Date:  2015-11-18

7.  Evaluating the disease and treatment information provided to patients with chronic obstructive pulmonary disease at the time of discharge according to GOLD discharge guidelines.

Authors:  Letícia de Araújo Morais; Samylla Ysmarrane Ismail Eisha de Sousa Cavalcante; Marcus Barreto Conde; Marcelo Fouad Rabahi
Journal:  Einstein (Sao Paulo)       Date:  2019-12-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.